Back to top

Corporate Summary

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.


•    Shares of biotech company Bacterin International Holdings Inc (AMEX:BONE) gained 10.34% after the company posted initial second quarter earnings figures that came in above expectations

•    U.S. listed shares of Check Point Software Technologies Ltd. (NASDAQ:CHKP) rose 8.11% after the network security provider released 2011 earnings forecasts exceeding the Street's expectations

•    According to a report in The Wall Street Journal, contract drug developer Pharmaceutical Product Development, Inc. (NASDAQ:PPDI) is looking to sell itself

•    Share prices of U.S. Gold Corporation (NYSE:UXG) gained 5.25% to close at $7.02 after gold futures moved above the $1,600 per ounce mark on the New York Mercantile Exchange

•    Bloomberg reported that Bank of America (NYSE:BAC) may further delay its plans to increase dividends because of mounting mortgage losses

•    Battery manufacturer Valence Technology, Inc.'s (NASDAQ:VLNC) shares gained 7.77% after the company increased  its first quarter revenue outlook for the fiscal year

•    Auto insurance company Allstate Corp.'s (NYSE:ALL) shares slipped 4.95% after Joseph Lacher, the president of the company decided to step down. Allstate is the second largest home and auto insurer in the United States

•    Stifel Nicolaus & Co. downgraded shares of semiconductor maker Entropic Communications Inc. (NASDAQ:ENTR) from "Buy" rating to "Sell" rating

•    Analysts at JP Morgan (NYSE:JPM) downgraded shares of social networking site LinkedIn (NYSE:LNKD) from "Overweight" rating to "Sell" rating. Reacting to the downgrade, the company’s shares fell 6.85% to close at $102.44

•    Shares of MGIC Investment Corp. (NYSE:MTG) lost 23.00% a day after the private-mortgage insurer reported second quarter losses due to a higher incidence of loan defaults

•    Share prices of Nabi Biopharmaceuticals (NASDAQ:NABI) plunged 66.43% after the pharma-company said its smoke-cessation drug has returned disappointing results

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
DIXIE GROUP DXYN 15.84 +7.90%
BOFL HOLDING BOFI 85.30 +4.97%
RAMBUS INC RMBS 12.31 +4.41%
VIPSHOP HOLD VIPS 148.73 +4.35%
NETFLIX INC NFLX 345.74 +4.32%